CBC

CBC Group (formerly C-Bridge Capital) is a leading healthcare-dedicated asset management firm and company builder headquartered in Singapore. The firm is unique in the biotech sector for its 'platform-building' strategy, where it identifies unmet medical needs in Asia and creates, funds, and operationally supports new biotechnology companies to address them. Through this model, CBC has incubated several high-profile entities including Everest Medicines, AffaMed Therapeutics, and NiKang Therapeutics. The group focuses on high-growth sectors such as oncology, immunology, and ophthalmology, leveraging a global network to license late-stage assets for the Asian market while developing internal R&D capabilities.